ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $63,161,000 | +4.5% | 1,363,314 | -45.0% | 0.02% | -20.0% |
| Q1 2019 | $60,435,000 | +48.1% | 2,478,886 | -13.4% | 0.02% | +25.0% |
| Q4 2018 | $40,798,000 | -24.1% | 2,863,024 | -19.1% | 0.02% | -5.9% |
| Q3 2018 | $53,777,000 | -15.2% | 3,538,029 | -6.4% | 0.02% | -19.0% |
| Q2 2018 | $63,408,000 | +25.6% | 3,778,747 | +22.1% | 0.02% | +10.5% |
| Q1 2018 | $50,490,000 | +7.7% | 3,093,830 | -15.5% | 0.02% | +11.8% |
| Q4 2017 | $46,878,000 | +71.2% | 3,662,296 | +64.5% | 0.02% | +70.0% |
| Q3 2017 | $27,379,000 | +72.8% | 2,226,002 | +17.6% | 0.01% | +100.0% |
| Q2 2017 | $15,842,000 | -39.9% | 1,892,728 | -35.8% | 0.01% | -44.4% |
| Q1 2017 | $26,364,000 | +55.8% | 2,949,039 | +53.2% | 0.01% | +50.0% |
| Q4 2016 | $16,922,000 | +30.2% | 1,925,148 | -0.0% | 0.01% | +50.0% |
| Q3 2016 | $12,998,000 | +23.7% | 1,925,674 | -16.5% | 0.00% | 0.0% |
| Q3 2015 | $10,511,000 | -24.5% | 2,305,104 | +19.4% | 0.00% | -20.0% |
| Q2 2015 | $13,919,000 | +4.2% | 1,930,539 | +6.5% | 0.01% | 0.0% |
| Q1 2015 | $13,363,000 | +6788.1% | 1,813,209 | +4587.2% | 0.01% | – |
| Q4 2013 | $194,000 | -94.3% | 38,684 | -93.0% | 0.00% | -100.0% |
| Q3 2013 | $3,424,000 | +38.0% | 550,468 | +0.7% | 0.00% | 0.0% |
| Q2 2013 | $2,481,000 | – | 546,443 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |